Internal Medicine, Nephrology · San Jose, CA
NPI
1003859661
Since 2006
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
3
Medicare group memberships
Hospitals
4
Hospital affiliations
105 N Bascom Ave, #103
San Jose, CA, 95128
Phone (408) 998-2890
Groups this clinician bills Medicare through
Medicare paid, 2024
$435K
7,815 services
Medicare patients, 2024
595
Average age 79
Drug cost, 2024
$5.1M
6,802 prescriptions
Company payments, 2025
$5,595
From 33 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Alexander D Doan was code 99454 (e&m - miscellaneous), 1,300 times for 200 patients. In total Alexander D Doan billed 7,815 services in 45 codes, and Medicare paid $435K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-08-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99454 E&M - Miscellaneous | Office | 1,300 | 200 | $48.22 | $63K |
| 99214 Office E&M - Established | Office | 1,185 | 323 | $104.93 | $124K |
| 99457 E&M - Miscellaneous | Office | 1,088 | 207 | $45.02 | $49K |
| 99458 E&M - Miscellaneous | Office | 829 | 193 | $35.06 | $29K |
| 99091 E&M - Miscellaneous | Office | 621 | 176 | $44.36 | $28K |
| 99232 Hospital E&M - Subsequent | Facility | 354 | 149 | $66.25 | $23K |
| 99233 Hospital E&M - Subsequent | Facility | 289 | 135 | $101.91 | $29K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 118 | 78 | $53.89 | $6,360 |
| 99223 Hospital E&M - Initial | Facility | 100 | 89 | $142.88 | $14K |
| 96372 Injection Administration | Office | 99 | 27 | $11.96 | $1,184 |
| 99239 Hospital Discharge Management | Facility | 94 | 89 | $102.49 | $9,634 |
| 99453 E&M - Miscellaneous | Office | 91 | 90 | $18.63 | $1,695 |
| 99204 Office E&M - New | Office | 54 | 54 | $118.57 | $6,403 |
| 99213 Office E&M - Established | Office | 33 | 24 | $62.34 | $2,057 |
| 81002 Clinical Chemistry | Office | 27 | 24 | $3.41 | $92.07 |
By year: 2022 $336K for 3,594 services; 2023 $363K for 4,761 services; 2024 $435K for 7,815 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81002 Clinical Chemistry | 27 | 24 | $3.41 | $92.07 |
Medicare prescription drug claims, 2024
In 2024, the drug Alexander D Doan prescribed most often to Medicare patients was Kerendia (Finerenone), with 344 prescriptions and refills. In total Alexander D Doan wrote 6,802 Medicare prescriptions that cost $5.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Kerendia Finerenone | 344 | 670 | 81 | $422K |
| Amlodipine Besylate Generic | 292 | 798 | 98 | $1,486 |
| Atorvastatin Calcium Generic | 259 | 755 | 86 | $1,821 |
| Furosemide Generic | 240 | 668 | 90 | $1,373 |
| Farxiga Dapagliflozin Propanediol | 234 | 510 | 59 | $278K |
| Valsartan Generic | 210 | 597 | 72 | $5,710 |
| Rayaldee Calcifediol | 173 | 187 | 27 | $193K |
| Metoprolol Succinate Generic | 169 | 489 | 53 | $1,993 |
| Losartan Potassium Generic | 158 | 460 | 60 | $1,673 |
| Ozempic Semaglutide | 149 | 235 | 36 | $214K |
| Rosuvastatin Calcium Generic | 140 | 370 | 39 | $2,534 |
| Veltassa Patiromer Calcium Sorbitex | 121 | 186 | 26 | $183K |
| Vascepa Icosapent Ethyl | 120 | 286 | 38 | $98K |
| Metformin Hcl Generic | 118 | 341 | 37 | $739 |
| Calcitriol Generic | 101 | 254 | 31 | $1,719 |
Brand drugs: 2,415 claims; generic drugs: 4,326 claims; opioid claims: 111.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Alexander D Doan $5,595 ($5,595 in general payments such as food, travel and fees) from 33 companies. The largest payer was Novo Nordisk Inc with $714.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 21 | $714 |
| AstraZeneca Pharmaceuticals LP AZN | 21 | $592 |
| Amgen Inc. AMGN | 21 | $585 |
| Novartis Pharmaceuticals Corporation NVS | 21 | $462 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 13 | $461 |
| Calliditas Therapeutics US Inc. | 12 | $336 |
| Corcept Therapeutics CORT | 8 | $301 |
| Mallinckrodt Hospital Products Inc. | 9 | $246 |
| Ardelyx, Inc. ARDX | 10 | $222 |
| ANI Pharmaceuticals, Inc. ANIP | 12 | $218 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.